Lori Friedman
Hoofd Techniek/Wetenschap/O&O bij ORIC PHARMACEUTICALS, INC.
Oorsprong van het eerstegraads netwerk van Lori Friedman
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021.
17
| Holding Company | Biotechnology | 17 |
| Public Company | Pharmaceuticals: Major | 15 | |
Project Scientist
1
| Non-Profit Organization | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Lori Friedman via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
AI Proteins, Inc.
 AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| IGNYTA INC | Biotechnology | General Counsel Chief Tech/Sci/R&D Officer Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| C4 THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member Founder Director/Board Member | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Founder Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
SanaRx Biotherapeutics, Inc.
 SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Microbial Machines, Inc. | Director/Board Member Chief Executive Officer Founder | ||
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Mana Therapeutics, Inc.
 Mana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mana Therapeutics, Inc. provides clinical cell immune therapies that can eliminate cancer cells. The company was founded by Catherine Bollard, Patrick Hanley, C. Russell Y. Cruz and Marc Cohen and is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Raqia Therapeutics, Inc. | Director/Board Member Director/Board Member | ||
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of California, Los Angeles | College/University | Doctorate Degree Masters Business Admin | |
OncoPep, Inc.
 OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Investment Managers | Director/Board Member Director/Board Member | |
| ALECTOR, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Director/Board Member | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
| Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Founder | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member Chairman | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chief Executive Officer Chairman | |
| GRITSTONE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal | |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| Purdue University | College/University | Doctorate Degree Graduate Degree | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Lightchain Capital LLC
 Lightchain Capital LLC Internet Software/ServicesTechnology Services Lightchain Capital LLC operates as single family office of Rodger Riney. It offers venture capital, software development and data science and has worked for major banks, investment firms and startups. The company was founded by Leo Semmelmann and Jan-Erik Flentje in 2007and is headquartered in St. Louis, MO. | Internet Software/Services | Corporate Officer/Principal Private Equity Investor | |
| MEDIVATION INC | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Thunderchild First Nation 115B
 Thunderchild First Nation 115B General GovernmentGovernment Thunderchild First Nation 115B operates as a council that provides economic development for the members of Thunderchild First Nation. The company is headquartered in Turtleford, Canada. | General Government | Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Moores Cancer Center | Corporate Officer/Principal | ||
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Consultant / Advisor | |
| PROTHENA CORPORATION PLC | Biotechnology | Corporate Officer/Principal | |
| Santa Clara University | College/University | Undergraduate Degree | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst |
Statistieken
Internationaal
| Verenigde Staten | 49 |
| Canada | 2 |
| Ierland | 2 |
Sectoraal
| Health Technology | 28 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 235 |
| Corporate Officer/Principal | 80 |
| Independent Dir/Board Member | 75 |
| Chief Tech/Sci/R&D Officer | 33 |
| Chairman | 27 |
Sterkste connecties
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Richard Heyman | 33 |
| Bobby Sandage | 29 |
| Lori Kunkel | 27 |
| Richard Scheller | 27 |
| Peter Svennilson | 25 |
| William McKee | 20 |
| Jacob Chacko | 18 |
| Mardi Dier | 18 |
| Kenneth Anderson | 17 |
| Pratik Multani | 16 |
| Fred H. Mermelstein | 16 |
| Angie You | 15 |
| Steven Hoerter | 12 |
| Elena Prokupets | 11 |
- Beurs
- Insiders
- Lori Friedman
- Bedrijfsconnecties
